S&P 500   4,986.30 (-0.50%)
DOW   37,923.01 (+0.39%)
QQQ   418.52 (-1.15%)
AAPL   165.02 (-1.21%)
MSFT   401.42 (-0.70%)
META   487.91 (-2.77%)
GOOGL   154.64 (-0.88%)
AMZN   176.10 (-1.74%)
TSLA   149.52 (-0.27%)
NVDA   821.64 (-2.96%)
AMD   149.78 (-3.42%)
NIO   3.86 (-3.50%)
BABA   68.86 (-0.03%)
T   16.34 (+0.06%)
F   12.12 (+0.50%)
MU   107.92 (-3.58%)
GE   150.69 (-1.47%)
CGC   8.04 (+2.68%)
DIS   111.69 (-0.66%)
AMC   3.19 (+9.25%)
PFE   25.81 (+1.65%)
PYPL   62.05 (-0.08%)
XOM   120.04 (+1.28%)
S&P 500   4,986.30 (-0.50%)
DOW   37,923.01 (+0.39%)
QQQ   418.52 (-1.15%)
AAPL   165.02 (-1.21%)
MSFT   401.42 (-0.70%)
META   487.91 (-2.77%)
GOOGL   154.64 (-0.88%)
AMZN   176.10 (-1.74%)
TSLA   149.52 (-0.27%)
NVDA   821.64 (-2.96%)
AMD   149.78 (-3.42%)
NIO   3.86 (-3.50%)
BABA   68.86 (-0.03%)
T   16.34 (+0.06%)
F   12.12 (+0.50%)
MU   107.92 (-3.58%)
GE   150.69 (-1.47%)
CGC   8.04 (+2.68%)
DIS   111.69 (-0.66%)
AMC   3.19 (+9.25%)
PFE   25.81 (+1.65%)
PYPL   62.05 (-0.08%)
XOM   120.04 (+1.28%)
S&P 500   4,986.30 (-0.50%)
DOW   37,923.01 (+0.39%)
QQQ   418.52 (-1.15%)
AAPL   165.02 (-1.21%)
MSFT   401.42 (-0.70%)
META   487.91 (-2.77%)
GOOGL   154.64 (-0.88%)
AMZN   176.10 (-1.74%)
TSLA   149.52 (-0.27%)
NVDA   821.64 (-2.96%)
AMD   149.78 (-3.42%)
NIO   3.86 (-3.50%)
BABA   68.86 (-0.03%)
T   16.34 (+0.06%)
F   12.12 (+0.50%)
MU   107.92 (-3.58%)
GE   150.69 (-1.47%)
CGC   8.04 (+2.68%)
DIS   111.69 (-0.66%)
AMC   3.19 (+9.25%)
PFE   25.81 (+1.65%)
PYPL   62.05 (-0.08%)
XOM   120.04 (+1.28%)
S&P 500   4,986.30 (-0.50%)
DOW   37,923.01 (+0.39%)
QQQ   418.52 (-1.15%)
AAPL   165.02 (-1.21%)
MSFT   401.42 (-0.70%)
META   487.91 (-2.77%)
GOOGL   154.64 (-0.88%)
AMZN   176.10 (-1.74%)
TSLA   149.52 (-0.27%)
NVDA   821.64 (-2.96%)
AMD   149.78 (-3.42%)
NIO   3.86 (-3.50%)
BABA   68.86 (-0.03%)
T   16.34 (+0.06%)
F   12.12 (+0.50%)
MU   107.92 (-3.58%)
GE   150.69 (-1.47%)
CGC   8.04 (+2.68%)
DIS   111.69 (-0.66%)
AMC   3.19 (+9.25%)
PFE   25.81 (+1.65%)
PYPL   62.05 (-0.08%)
XOM   120.04 (+1.28%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agilysys, Inc. stock logo
AGYS
Agilysys
$81.92
+0.2%
$80.84
$62.00
$91.61
$2.24B0.66203,611 shs27,653 shs
Ebix, Inc. stock logo
EBIX
Ebix
$3.51
$1.05
$32.87
$35.85M2.371.20 million shs12.34 million shs
NextGen Healthcare, Inc. stock logo
NXGN
NextGen Healthcare
$23.94
$23.89
$15.23
$23.98
$1.61B0.77659,586 shsN/A
OneSpan Inc. stock logo
OSPN
OneSpan
$10.06
+1.4%
$10.43
$7.64
$17.20
$380.17M0.8386,382 shs41,038 shs
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$44.92
+1.1%
$43.15
$32.69
$52.69
$897.95M0.72109,162 shs15,461 shs
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agilysys, Inc. stock logo
AGYS
Agilysys
-0.76%-0.16%+4.92%-1.32%-1.12%
Ebix, Inc. stock logo
EBIX
Ebix
0.00%0.00%0.00%0.00%-93.39%
NextGen Healthcare, Inc. stock logo
NXGN
NextGen Healthcare
0.00%0.00%0.00%0.00%+34.65%
OneSpan Inc. stock logo
OSPN
OneSpan
+0.61%-4.52%-6.94%-4.71%-41.27%
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
-0.65%-7.19%+2.68%+15.35%+3.66%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Agilysys, Inc. stock logo
AGYS
Agilysys
2.4479 of 5 stars
1.55.00.00.02.45.01.3
Ebix, Inc. stock logo
EBIX
Ebix
1.6193 of 5 stars
3.00.00.80.00.62.51.3
NextGen Healthcare, Inc. stock logo
NXGN
NextGen Healthcare
0.1779 of 5 stars
1.00.00.00.00.01.71.9
OneSpan Inc. stock logo
OSPN
OneSpan
4.2089 of 5 stars
2.05.00.03.82.33.31.9
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
1.7738 of 5 stars
2.50.00.80.02.54.21.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agilysys, Inc. stock logo
AGYS
Agilysys
3.00
Buy$88.758.05% Upside
Ebix, Inc. stock logo
EBIX
Ebix
2.00
Hold$5.00∞ Upside
NextGen Healthcare, Inc. stock logo
NXGN
NextGen Healthcare
2.00
Hold$21.98-8.17% Downside
OneSpan Inc. stock logo
OSPN
OneSpan
2.00
Hold$12.0020.85% Upside
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
3.00
Buy$53.0017.91% Upside

Current Analyst Ratings

Latest AGYS, EBIX, NXGN, OSPN, and SLP Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/2/2024
OneSpan Inc. stock logo
OSPN
OneSpan
Sidoti
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$12.00
1/23/2024
Agilysys, Inc. stock logo
AGYS
Agilysys
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$92.00 ➝ $100.00
(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agilysys, Inc. stock logo
AGYS
Agilysys
$198.07M11.35$1.21 per share68.16$4.34 per share18.93
Ebix, Inc. stock logo
EBIX
Ebix
$735.63M0.00N/A0.35$21.34 per share0.00
NextGen Healthcare, Inc. stock logo
NXGN
NextGen Healthcare
$653.17M2.46$1.16 per share20.57$6.31 per share3.79
OneSpan Inc. stock logo
OSPN
OneSpan
$235.11M1.60N/AN/A$3.99 per share2.49
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$59.58M15.08$0.83 per share53.96$8.86 per share5.07

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agilysys, Inc. stock logo
AGYS
Agilysys
$14.58M$3.1925.75149.35N/A38.27%20.54%10.64%5/21/2024 (Estimated)
Ebix, Inc. stock logo
EBIX
Ebix
$64.64M$0.176.82N/AN/A0.67%4.15%1.79%N/A
NextGen Healthcare, Inc. stock logo
NXGN
NextGen Healthcare
-$2.65M-$0.10N/A27.52N/A-0.89%11.37%5.38%N/A
OneSpan Inc. stock logo
OSPN
OneSpan
-$29.80M-$0.74N/A11.28N/A-12.68%-6.43%-3.91%5/2/2024 (Confirmed)
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$9.96M$0.5384.81N/A16.22%7.95%7.35%7/4/2024 (Estimated)

Latest AGYS, EBIX, NXGN, OSPN, and SLP Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2024N/A
OneSpan Inc. stock logo
OSPN
OneSpan
$0.21N/A-$0.21N/AN/AN/A  
4/3/2024Q2 2024
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$0.18$0.20+$0.02$0.20$17.31 million$18.31 million      
3/6/2024Q4 2023
OneSpan Inc. stock logo
OSPN
OneSpan
-$0.05$0.12+$0.17$0.23N/A$62.93 million    
1/22/202412/31/2023
Agilysys, Inc. stock logo
AGYS
Agilysys
$0.26$0.35+$0.09-$2.15$60.07 million$60.57 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Agilysys, Inc. stock logo
AGYS
Agilysys
N/AN/AN/AN/AN/A
Ebix, Inc. stock logo
EBIX
Ebix
$0.07N/AN/A41.18%N/A
NextGen Healthcare, Inc. stock logo
NXGN
NextGen Healthcare
N/AN/AN/AN/AN/A
OneSpan Inc. stock logo
OSPN
OneSpan
N/AN/AN/AN/AN/A
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$0.240.53%-20.63%45.28%N/A

Latest AGYS, EBIX, NXGN, OSPN, and SLP Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/3/2024
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
Quarterly$0.060.5%4/26/20244/29/20245/6/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agilysys, Inc. stock logo
AGYS
Agilysys
N/A
2.01
1.94
Ebix, Inc. stock logo
EBIX
Ebix
N/A
0.41
0.41
NextGen Healthcare, Inc. stock logo
NXGN
NextGen Healthcare
0.63
2.52
2.52
OneSpan Inc. stock logo
OSPN
OneSpan
N/A
1.27
1.14
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
N/A
8.81
8.81

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Agilysys, Inc. stock logo
AGYS
Agilysys
88.00%
Ebix, Inc. stock logo
EBIX
Ebix
66.08%
NextGen Healthcare, Inc. stock logo
NXGN
NextGen Healthcare
76.65%
OneSpan Inc. stock logo
OSPN
OneSpan
95.52%
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
78.08%

Insider Ownership

CompanyInsider Ownership
Agilysys, Inc. stock logo
AGYS
Agilysys
23.60%
Ebix, Inc. stock logo
EBIX
Ebix
15.90%
NextGen Healthcare, Inc. stock logo
NXGN
NextGen Healthcare
4.60%
OneSpan Inc. stock logo
OSPN
OneSpan
0.78%
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
20.90%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Agilysys, Inc. stock logo
AGYS
Agilysys
1,60027.36 million20.90 millionOptionable
Ebix, Inc. stock logo
EBIX
Ebix
10,52130.90 million25.99 millionNot Optionable
NextGen Healthcare, Inc. stock logo
NXGN
NextGen Healthcare
2,78367.10 million64.01 millionOptionable
OneSpan Inc. stock logo
OSPN
OneSpan
67637.79 million37.50 millionOptionable
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
19219.99 million15.81 millionOptionable

AGYS, NXGN, OSPN, SLP, and EBIX Headlines

SourceHeadline
Simulations Plus Inc.Simulations Plus Inc.
wsj.com - April 17 at 5:46 PM
Simulations Plus (NASDAQ:SLP): Promising Potential in Biotech SoftwareSimulations Plus (NASDAQ:SLP): Promising Potential in Biotech Software
msn.com - April 16 at 11:14 AM
SLP Sep 2024 55.000 callSLP Sep 2024 55.000 call
finance.yahoo.com - April 15 at 6:31 PM
New AI Bot Predicts These 7 Stocks Will Mint MillionairesNew AI Bot Predicts These 7 Stocks Will Mint Millionaires
investorplace.com - April 12 at 1:53 PM
Simulations Plus, Inc. (NASDAQ:SLP) Shares Acquired by Conestoga Capital Advisors LLCSimulations Plus, Inc. (NASDAQ:SLP) Shares Acquired by Conestoga Capital Advisors LLC
marketbeat.com - April 10 at 3:54 PM
Simulations Plus (NASDAQ:SLP) Stock Price Up 5.2%Simulations Plus (NASDAQ:SLP) Stock Price Up 5.2%
marketbeat.com - April 8 at 2:30 PM
Simulations Plus (SLP) DILIsym Software Licenses Renewed by FDASimulations Plus (SLP) DILIsym Software Licenses Renewed by FDA
zacks.com - April 8 at 10:10 AM
Simulations Plus, Inc. (SLP) Q2 2024 Earnings Call TranscriptSimulations Plus, Inc. (SLP) Q2 2024 Earnings Call Transcript
seekingalpha.com - April 6 at 3:58 PM
Earnings Update: Simulations Plus, Inc. Beat Earnings And Now Analysts Have New Forecasts For This YearEarnings Update: Simulations Plus, Inc. Beat Earnings And Now Analysts Have New Forecasts For This Year
finance.yahoo.com - April 6 at 10:39 AM
Simulations Plus Second Quarter 2024 Earnings: Beats ExpectationsSimulations Plus Second Quarter 2024 Earnings: Beats Expectations
finance.yahoo.com - April 5 at 9:07 AM
Simulations Plus, Inc. to Issue Quarterly Dividend of $0.06 (NASDAQ:SLP)Simulations Plus, Inc. to Issue Quarterly Dividend of $0.06 (NASDAQ:SLP)
marketbeat.com - April 5 at 7:30 AM
Simulations Plus Shares Rise 27% Following FDAs License Renewal for Dilisym Software PlatformSimulations Plus Shares Rise 27% Following FDA's License Renewal for Dilisym Software Platform
marketwatch.com - April 4 at 11:06 PM
Simulations Plus (NASDAQ:SLP) Shares Gap Up  After Strong EarningsSimulations Plus (NASDAQ:SLP) Shares Gap Up After Strong Earnings
marketbeat.com - April 4 at 1:20 PM
Simulations Plus stock jumps 25% amid FDA renewal, earnings reportSimulations Plus stock jumps 25% amid FDA renewal, earnings report
msn.com - April 4 at 1:05 PM
Simulations Plus, Inc. (NASDAQ:SLP) Q2 2024 Earnings Call TranscriptSimulations Plus, Inc. (NASDAQ:SLP) Q2 2024 Earnings Call Transcript
finance.yahoo.com - April 4 at 1:05 PM
Simulations Plus (NASDAQ:SLP) Posts Quarterly  Earnings Results, Beats Expectations By $0.02 EPSSimulations Plus (NASDAQ:SLP) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS
marketbeat.com - April 4 at 11:58 AM
U.S. FDA Renews DILIsym® Software Licenses for 7th YearU.S. FDA Renews DILIsym® Software Licenses for 7th Year
businesswire.com - April 4 at 8:30 AM
Q2 2024 Simulations Plus Inc Earnings CallQ2 2024 Simulations Plus Inc Earnings Call
finance.yahoo.com - April 4 at 8:04 AM
Simulations Plus (SLP) Q2 Earnings & Revenues Beat EstimatesSimulations Plus (SLP) Q2 Earnings & Revenues Beat Estimates
zacks.com - April 4 at 7:36 AM
Simulations Plus, Inc. 2024 Q2 - Results - Earnings Call PresentationSimulations Plus, Inc. 2024 Q2 - Results - Earnings Call Presentation
seekingalpha.com - April 3 at 11:16 PM
SLP Stock Earnings: Simulations Plus Beats EPS, Beats Revenue for Q2 2024SLP Stock Earnings: Simulations Plus Beats EPS, Beats Revenue for Q2 2024
investorplace.com - April 3 at 10:05 PM
Simulations Plus: Fiscal Q2 Earnings SnapshotSimulations Plus: Fiscal Q2 Earnings Snapshot
washingtonpost.com - April 3 at 9:01 PM
Simulations Plus Inc (SLP) Aligns with EPS Projections and Maintains Full-Year GuidanceSimulations Plus Inc (SLP) Aligns with EPS Projections and Maintains Full-Year Guidance
finance.yahoo.com - April 3 at 9:01 PM
Simulations Plus (SLP) Q2 Earnings and Revenues Surpass EstimatesSimulations Plus (SLP) Q2 Earnings and Revenues Surpass Estimates
zacks.com - April 3 at 6:21 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Agilysys logo

Agilysys

NASDAQ:AGYS
Agilysys, Inc., together with its subsidiaries, operates as a developer and marketer of hardware and software products and services to the hospitality industry in North America, Europe, the Asia-Pacific, and India. It offers point of sale, property management systems, inventory and procurement, payments, activity scheduling, reservations management, and related solutions to enhance guest experience. The company also provides cloud applications, support, maintenance, and subscription services; and professional services. It offers its solutions for hotels, resorts and cruise lines, casinos, corporate food service management, restaurants, universities, stadiums, and healthcare applications. The company was formerly known as Pioneer-Standard Electronics, Inc. and changed its name to Agilysys, Inc. in 2003. Agilysys, Inc. was founded in 1932 and is headquartered in Alpharetta, Georgia.
Ebix logo

Ebix

NASDAQ:EBIX
Ebix, Inc., together with its subsidiaries, provides on-demand infrastructure software exchanges and e-commerce services to the insurance, financial, travel, cash remittance, and healthcare industries in the United States and internationally. The company develops and deploys insurance and reinsurance exchanges on an on-demand basis using software-as-a-service (SaaS) enterprise solutions in the areas of customer relationship management, front-end and back-end systems, and outsourced administrative and risk compliance solutions. Its EbixCash exchange related products and services include gift cards; travel exchanges services; money transfer services; foreign exchange and outward remittance services; consumer payment services; and on-demand technology to various providers in the areas of lending, wealth and asset management, and travel. The company's insurance exchanges related products and services include SaaS platform and related services; licensing of software; and professional services comprising setup, customization, training, or consulting. Its risk compliance services cover certificates of insurance creation and tracking; consulting services, such as project management, integration, development, and testing; and business process outsourcing services, including domain intensive project management, system consulting services, and claims adjudication/settlement services. The company was formerly known as Delphi Systems, Inc. and changed its name to Ebix, Inc. in December 2003. Ebix, Inc. was founded in 1976 and is headquartered in Johns Creek, Georgia. On December 17, 2023, Ebix, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Northern District of Texas.
NextGen Healthcare logo

NextGen Healthcare

NASDAQ:NXGN
NextGen Healthcare, Inc. provides healthcare technology solutions in the United States. The company offers clinical care solutions, including NextGen Enterprise EHR; financial solutions, such as NextGen Enterprise PM; patient engagement solutions comprising NextGen Virtual Visits; integrated clinical care and financial solutions consisting of NextGen Office; interoperability solutions that include NextGen Share and Mirth Connect; data and analytics solutions, which comprise NextGen Health Data Hub; and value based care solutions, including NextGen Population Health Solutions. It also provides managed services, such as revenue cycle management services comprising billing and collections, electronic claims submission and denials management, electronic remittance and payment posting, and accounts receivable follow-up; and client and support services. Further, the company offers professional services consisting of training, project management, installation services, and application managed services; and consulting services that include physician, professional, and technical consulting; assisting clients to optimize their staffing and software solutions; enhancing financial and clinical outcomes; achieving regulatory requirements; and meeting the requirements of healthcare reform. It serves accountable care organizations, independent physician associations, managed service organizations, veterans service organizations, dental service organizations, ambulatory care centers, and community health centers through a direct sales force and reseller channel. The company was formerly known as Quality Systems, Inc. and changed its name to NextGen Healthcare, Inc. in September 2018. NextGen Healthcare, Inc. was incorporated in 1974 and is based in Atlanta, Georgia.
OneSpan logo

OneSpan

NASDAQ:OSPN
OneSpan Inc., together with its subsidiaries, designs, develops, and markets digital solutions for identity, authentication, and secure digital agreements worldwide. The company offers OneSpan Sign, a range of e-signature requirements for occasional agreement to processing tens of thousands of transactions; OneSpan Cloud Authentication, a cloud-based multifactor authentication solution that supports a range of authentication options, including biometrics, push notification, and visual cryptograms for transaction data security, SMS, and hardware authenticators; and OneSpan Identity Verification, which enables banks and financial institutions identity verification services. It also provides Mobile Security Suite, a software development kit that protect mobile transactions; Digipass Authenticators, consisting of a wide variety of authentication devices; authentication servers that provides a range of strong authentication utilities and solutions designed to allow organizations to securely authenticate users and transactions; and Digipass FX1 BIO, a physical passkey with fingerprint scan built for the workforce authentication market. In addition, it offers Virtual Room, a purpose-built, high-assurance solution that blends the simplicity of a consumer video collaboration app with high-assurance identity and authentication security; OneSpan Notary, an online notary solution developed for organizations with in-house notaries; and OneSpan Trust Vault, a blockchain-based decentralized digital storage solution that helps organizations meet compliance, regulatory, and chain of custody requirements for critical documents. It sells its solutions through its direct sales force, as well as through distributors, resellers, systems integrators, and original equipment manufacturers. The company was formerly known as VASCO Data Security International, Inc. and changed its name to OneSpan Inc. in May 2018. OneSpan Inc. was founded in 1991 and is headquartered in Boston, Massachusetts.
Simulations Plus logo

Simulations Plus

NASDAQ:SLP
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. The company also provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, RENAsym, IPFsym, and MITOsym products. In addition, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Further, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Additionally, it offers creative and insightful consulting services to support its quantitative systems pharmacology/quantitative systems toxicology modelling. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.